Capital Directions Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$276K Buy
+754
New +$267K 0.1% 51
2022
Q3
Sell
-670
Closed -$212K 64
2022
Q2
$217K Buy
670
+200
+43% +$60K 0.07% 67
2022
Q1
$135K Buy
+470
New +$121K 0.04% 80
2021
Q4
Sell
-470
Closed -$109K 144
2021
Q3
$109K Hold
470
0.03% 87
2021
Q2
$108K Buy
+470
New +$94.4K 0.03% 79
2021
Q1
Sell
-470
Closed -$79K 278
2020
Q4
$79K Hold
470
0.03% 84
2020
Q3
$70K Hold
470
0.03% 88
2020
Q2
$77K Sell
470
-315
-40% -$48.4K 0.03% 85
2020
Q1
$109K Hold
785
0.05% 71
2019
Q4
$103K Hold
785
0.03% 88
2019
Q3
$88K Buy
+785
New +$87.4K 0.03% 91
2018
Q3
Sell
-1,120
Closed -$96K 192
2018
Q2
$96K Buy
+1,120
New +$92K 0.05% 50

Other funds holding LLY

Capital Directions Investment Advisors's LLY Position: Q4 2022 in Review

Capital Directions Investment Advisors opened a new position in Eli Lilly (LLY) in Q4 2022: 754 shares worth $276K. The stake represents 0.1% of the portfolio and ranks #51 among its holdings. This is a return to the name: Capital Directions Investment Advisors previously reported a position in LLY as recently as Q2 2022.

Capital Directions Investment Advisors first reported a position in LLY in Q2 2018 and has held it in 12 quarters since. 2,672 funds tracked by Wall St. Rank hold LLY as of Q4 2022.

  • Capital Directions Investment Advisors held 754 shares of Eli Lilly worth $276K as of Q4 2022.
  • Eli Lilly was a new Capital Directions Investment Advisors position in Q4 2022.
  • Eli Lilly made up 0.1% of Capital Directions Investment Advisors's portfolio in Q4 2022, its #51 holding.
  • Capital Directions Investment Advisors first reported a position in Eli Lilly in Q2 2018 and has held it in 12 quarters since.
  • 2,672 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2022.

Based on Capital Directions Investment Advisors's 13F filing for Q4 2022, filed 1 Feb 2023.